Cargando…
Epac1 agonist decreased inflammatory proteins in retinal endothelial cells, and loss of Epac1 increased inflammatory proteins in the retinal vasculature of mice
PURPOSE: Increased inflammatory mediator levels are reported in diabetic retinopathy. We previously reported that β-adrenergic receptor agonists reduced inflammatory mediators in the diabetic retina; however, these agents cannot be given systemically. Here, we investigated whether Epac1 is key to th...
Autores principales: | Liu, Li, Jiang, Youde, Chahine, Adam, Curtiss, Elizabeth, Steinle, Jena J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5287445/ https://www.ncbi.nlm.nih.gov/pubmed/28210097 |
Ejemplares similares
-
Epac1 Blocks NLRP3 Inflammasome to Reduce IL-1β in Retinal Endothelial Cells and Mouse Retinal Vasculature
por: Jiang, Youde, et al.
Publicado: (2017) -
Epac1 Requires AMPK Phosphorylation to Regulate HMGB1 in the Retinal Vasculature
por: Jiang, Youde, et al.
Publicado: (2020) -
PKA and Epac1 Reduce Nek7 to Block the NLRP3 Inflammasome Proteins in the Retinal Vasculature
por: Liu, Li, et al.
Publicado: (2022) -
Epac1 and PKA agonists inhibit ROS to reduce NLRP3 inflammasome proteins in retinal endothelial cells
por: Liu, Li, et al.
Publicado: (2022) -
Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
por: Jiang, Youde, et al.
Publicado: (2019)